- Press Release
- Middle East & Africa Animal Healthcare Market to Surpass US$ 5,521.4 Million by 2027
Middle East & Africa Animal Healthcare Market to Surpass US$ 5,521.4 Million by 2027 - Coherent Market Insights
Published On : Sep 18, 2020
Middle East & Africa Animal Healthcare Market, By Product Type (Anti-infective, Anti-inflammatory, Vaccines (FMD Vaccines, Rabies Vaccines, and Others), Hormones & Substitutes, and Others), By Animal Type (Livestock (Bovine, Porcine, Ovine, and Poultry), and Companion (Canine and Feline)), By Route of Administration (Oral and Parenteral), By Disease Indication (Viral Diseases, Bacterial Diseases, Fungal Diseases, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, and Online Pharmacies), and By Region (Middle East and Africa), is estimated to be valued at US$ 3,883.0 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Key players in the market are focusing on launch of animal healthcare products, which is expected to support growth of the market. For instance, in August 2017, Boehringer Ingelheim announced the launch of Centragard, a transdermal solution for the treatment and control of three of the most common intestinal parasites of cats such as hookworms, roundworms, and tapeworms.
Similarly, in 2019, Bayer Animal Health announced the launch of Coraxis, a topical solution for dogs, for the prevention of heartworm disease and to control hookworms, roundworms, and whipworms.
Middle East & Africa Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic.
The Food and Agriculture Organization of the United Nations provided guidelines to mitigate the impact of the COVID-19 pandemic on livestock production and animal health, which included the following recommendations for the livestock farmers to prevent spread of the coronavirus infection.
Browse 75 Market Data Tables and 44 Figures spread through 244 Pages and in-depth TOC on “Animal Healthcare Market”- Middle East & Africa Forecast to 2027, By Product Type (Anti-infective, Anti-inflammatory, Vaccines (FMD Vaccines, Rabies Vaccines, and Others), Hormones & Substitutes, and Others), By Animal Type (Livestock (Bovine, Porcine, Ovine, and Poultry), and Companion (Canine and Feline)), By Route of Administration (Oral and Parenteral), By Disease Indication (Viral Diseases, Bacterial Diseases, Fungal Diseases, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, and Online Pharmacies), and By Region (Middle East and Africa)
To know the latest trends and insights prevalent in the Middle East & Africa animal healthcare market, click the link below:
Middle East & Africa animal healthcare market is expected to witness significant growth due to the increasing funding and investment through public-private collaborations. For instance, in October 2018, The African Livestock Productivity and Health Advancement (A.L.P.H.A.), in collaboration with Zoetis, received US$ 14.4 Mn grant from the Bill & Melinda Gates Foundation to improve animal health in the region.
Key Takeaways of the Middle East & Africa Animal Healthcare Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.